Literature DB >> 23712608

Genetic variability related to serum uric acid concentration and risk of Parkinson's disease.

Isabel González-Aramburu1, Pascual Sánchez-Juan, Silvia Jesús, Ana Gorostidi, Eduardo Fernández-Juan, Fátima Carrillo, María Sierra, Pilar Gómez-Garre, María T Cáceres-Redondo, José Berciano, Javier Ruiz-Martínez, Onofre Combarros, Pablo Mir, Jon Infante.   

Abstract

BACKGROUND: Low serum uric acid (UA) levels have been associated with increased Parkinson's disease (PD) risk and accelerated disease progression. We analyzed the effect of polymorphisms in 9 genes influencing serum UA concentration on the risk of PD.
METHODS: We genotyped SLC2A9 rs734553, ABCG2 rs2231142, SLC17A1 rs1183201, SLC22A11 rs17300741, SLC22A12 rs505802, GCKR rs780094, PDZK1 rs12129861, LRRC16A+SCGN rs742132, and SLC16A9 rs12356193 in 1061 PD patients and 754 controls. For each subject we calculated a cumulative genetic risk score (GRS), defined as the total number of PD-risk alleles (range, 2-15) associated to lower serum UA levels. Serum UA levels were measured in a subgroup of 365 PD cases and 132 controls.
RESULTS: Serum UA levels were significantly lower in men with PD than in controls. Subjects (both men and women) carrying more than 9 risk alleles (third GRS tertile) had a 1.5 higher risk of developing PD than subjects with less than 8 risk alleles (first GRS tertile). An inverse correlation was observed between higher GRS and lower serum UA concentration in both men and women.
CONCLUSIONS: Genetic variability influencing serum UA levels might modify susceptibility to PD.
Copyright © 2013 Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; genetics; uric acid

Mesh:

Substances:

Year:  2013        PMID: 23712608     DOI: 10.1002/mds.25507

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  22 in total

1.  Mendelian randomization of serum urate and parkinson disease progression.

Authors:  Kelly Claire Simon; Shirley Eberly; Xiang Gao; David Oakes; Caroline M Tanner; Ira Shoulson; Stanley Fahn; Michael A Schwarzschild; Alberto Ascherio
Journal:  Ann Neurol       Date:  2014-10-03       Impact factor: 10.422

Review 2.  Drug Repurposing in Parkinson's Disease.

Authors:  Dilan Athauda; Thomas Foltynie
Journal:  CNS Drugs       Date:  2018-08       Impact factor: 5.749

Review 3.  Urate as a Marker of Risk and Progression of Neurodegenerative Disease.

Authors:  Sabrina Paganoni; Michael A Schwarzschild
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

4.  Pathway for ascertaining the role of uric acid in neurodegenerative diseases.

Authors:  Youssef Roman
Journal:  Alzheimers Dement (Amst)       Date:  2022-06-21

5.  Urate levels predict survival in amyotrophic lateral sclerosis: Analysis of the expanded Pooled Resource Open-Access ALS clinical trials database.

Authors:  Sabrina Paganoni; Katharine Nicholson; James Chan; Amy Shui; David Schoenfeld; Alexander Sherman; James Berry; Merit Cudkowicz; Nazem Atassi
Journal:  Muscle Nerve       Date:  2017-09-21       Impact factor: 3.217

Review 6.  Purines: forgotten mediators in traumatic brain injury.

Authors:  Edwin K Jackson; Detlev Boison; Michael A Schwarzschild; Patrick M Kochanek
Journal:  J Neurochem       Date:  2016-02-25       Impact factor: 5.372

7.  Prospective study of plasma urate and risk of Parkinson disease in men and women.

Authors:  Xiang Gao; Éilis J O'Reilly; Michael A Schwarzschild; Alberto Ascherio
Journal:  Neurology       Date:  2016-01-13       Impact factor: 9.910

8.  The cardiometabolic benefits of glycine: Is glycine an 'antidote' to dietary fructose?

Authors:  Mark F McCarty; James J DiNicolantonio
Journal:  Open Heart       Date:  2014-05-28

9.  ABCG2 variant has opposing effects on onset ages of Parkinson's disease and gout.

Authors:  Hirotaka Matsuo; Hiroyuki Tomiyama; Wataru Satake; Toshinori Chiba; Hiroyuki Onoue; Yusuke Kawamura; Akiyoshi Nakayama; Seiko Shimizu; Masayuki Sakiyama; Manabu Funayama; Kenya Nishioka; Toru Shimizu; Kenichi Kaida; Keiko Kamakura; Tatsushi Toda; Nobutaka Hattori; Nariyoshi Shinomiya
Journal:  Ann Clin Transl Neurol       Date:  2015-01-19       Impact factor: 4.511

Review 10.  Mendelian Randomization - the Key to Understanding Aspects of Parkinson's Disease Causation?

Authors:  Alastair J Noyce; Mike A Nalls
Journal:  Mov Disord       Date:  2015-12-23       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.